Preventive therapy in postoperative Crohn's disease

Current Opinion in Gastroenterology

Volumn 26, Issue 4, 2010, Pages 337-343

  Swoger, Jason M ^a   Regueiro, Miguel ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Crohn's disease; Disease recurrence; Postoperative therapy; Prevention

Indexed keywords

AZATHIOPRINE; CALGRANULIN; ENEMA; INFLIXIMAB; LACTOFERRIN; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; NITROIMIDAZOLE; PLACEBO; PROBIOTIC AGENT; SACCHAROMYCES CEREVISIAE ANTIBODY; SACCHAROMYCES CEREVISIAE PROTEIN; UNCLASSIFIED DRUG; VSL3; ANTIINFLAMMATORY AGENT; GASTROINTESTINAL AGENT;

ADD ON THERAPY; CIGARETTE SMOKING; CLINICAL TRIAL; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CROHN DISEASE; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ECHOGRAPHY; FAMILY HISTORY; FECES ANALYSIS; HUMAN; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREDICTOR VARIABLE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WOUND HEALING IMPAIRMENT; CHEMISTRY; ENDOSCOPIC ECHOGRAPHY; FECES; GENETICS; POSTOPERATIVE COMPLICATIONS; SMOKING; TIME;

ANTI-INFLAMMATORY AGENTS; COLONOSCOPY; CROHN DISEASE; ENDOSONOGRAPHY; FECES; GASTROINTESTINAL AGENTS; HUMANS; LACTOFERRIN; LEUKOCYTE L1 ANTIGEN COMPLEX; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RISK FACTORS; SMOKING; TIME FACTORS;

EID: 77954111733     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328338f724     Document Type: Review

References (40)

1. Cosnes J, Nion-Larmurier I, Beaugerie L, et al. Impact of increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005; 54:237-241.
2. Bennell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000; 2312:38-45.
3. Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990; 99:956-983.
4. Olaison G, Smedh K, Sjodahl R. Natural course of Crohn's disease after ileocolic resection: endoscopically visualized ileal ulcers preceding symptoms. Gut 1992; 33:331-335.
5. Chardavoyne R, Flint GW, Pollack S, et al. Factors affecting recurrence following resection for Crohn's disease. Dis Colon Rectum 1986; 29:495-502.
6. Landsend E, Johnson E, Johannessen HO, et al. Long-term outcome after intestinal resection for Crohn's disease. Scand J Gastroenterol 2006; 41:1204-1208.
7. Lock MR, Farmer RG, Fazio VW, et al. Recurrence and reoperation for Crohn's disease. N Engl J Med 1982; 394:1586-1588.
8. Reese GE, Nanidis T, Borysiewicz C, et al. The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies. Int J Colorectal Dis 2008; 23:1213-1221.
9. Unkart JT, Anderson L, Li E, et al. Riskfactors for surgical recurrence after ileocolic resection of Crohn's disease. Dis Colon Rectum 2008; 51:1211-1216.
10. Sachar DB, Lemmer E, Ibrahim C, et al. Recurrence patterns after first resection for stricturing or penetrating Crohn's disease. Inflamm Bowel Dis 2009; 15:1071-1075.
11. McLeod RS, Wolff BG, Ross S, et al. Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum 2009; 52:919-927.
12. McGovern DP, Taylor KD, Landers CJ, et al. Clinical, serological and genetic predicators of postoperative recurrence in a single-center prospectively collected cohort of Crohn's disease patients [abstract]. Gastroenterology 2008; 134 (Suppl 1):A-202.
13. Stone CD, Chen J, Unkart JT, et al. Serology testing, genotype, and other risk factors for repeat ileocolic resection in Crohn's disease: a time-to-event analysis [abstract]. Gastroenterology 2008; 134 (Suppl 1):A-637-638.
14. Maconi G, Colombo E, Sampietro GM, et al. CARD 15 gene variants and risk of reoperation in Crohn's disease patients. Am J Gastroenterol 2009; 104:2483-2491.
15. Gorbe E, Chen J, Reimers MA, et al. NOD2 risk alleles combined with habitual cigarette smoking accelerate the time to second ileocolic resection in Crohn's disease [abstract]. Gastroenterology 2009; 136 (Suppl 1):A-207.
16. Lamb CA, Mohiuddin MK, Gicquel J, et al. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease. Br J Surg 2009; 96:663-674.
17. Calabrese E, Petruzziello C, Inali S, et al. Severity of postoperative recurrence in Crohn's disease: correlation between endoscopic and sonographic findings. Inflamm Bowel Dis 2009; 15:1635-1642.
18. Castiglione F, Bucci L, Pesce G, et al. Oral contrast-enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease. Inflamm Bowel Dis 2008; 14:1240-1245.
19. Pallotta N, Barberani F, Giovannone M, et al. Ultrasound assessment of the degree of transmural lesions predicts the severity of endoscopic lesions of the ileo-colonic anastomosis after 'curative' ileal resection in Crohn's disease [abstract]. Gastroenterology 2009; 136 (Suppl 1):A-99.
20. Sailer J, Peloschek P, Reinisch W, et al. Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopy. Eur Radiol 2008; 18:2512-2521.
21. Doherty G, Bennett G, Patil S, et al. Interventions for prevention of post-operative recurrence of Crohn's disease. Cochrane Database Syst Rev 2009; Art. No.: CD006873. doi: 10.1002/14651858.CD006873.pub2.
22. Cho SM, Cho SW, Regueiro M. Postoperative management of Crohn's disease. Gastroenterol Clin North Am 2009; 38:753-762.
23. Ng SC, Kamm MA. Management of postoperative Crohn's disease. Am J Gastroenterol 2008; 103:1029-1035.
24. Regueiro M. Management and prevention of postoperative Crohn's disease. Inflamm Bowel Dis 2009; 15:1583-1590.
25. Terdiman JP. Prevention of postoperative recurrence in Crohn's disease. Clin Gastroenterol Hepatol 2008; 6:616-620.
26. Blum E, Katz J. Postoperative therapy for Crohn's disease. Inflamm Bowel Dis 2009; 15:463-472.
27. Clarke K, Regueiro M. Prevention and treatment options for postoperative Crohn's disease: a clinical dilemma. Gastroenterol Hepatol 2009; 5:581-588.
28. El-Hachem S, Regueiro M. Postoperative Crohn's disease: prevention and treatment. Expert Rev Gastroenterol Hepatol 2009; 3:249-256.
29. Doherty GA, Bennett G, Patil S, et al. Meta-analysis of mesalamine in the prevention of postoperative recurrence of Crohn's disease [abstract]. Gastroenterology 2009; 136 (Suppl 1):A-522.
30. Reinisch W, Angelberger S, Petritsch W, et al. A double-blind, double-dummy, randomized, controlled, multicenter trial on the efficacy and safety of azathioprine vs. mesalamine for the prevention of clinical relapses in Crohn's disease patients with postoperative moderate or severe endoscopic recurrence [abstract]. Gastroenterology 2008; 134 (Suppl 1):A-70.
31. Madsen K, Backer JL, Leddin D, et al. A randomized controlled trial of VSL#3 for the prevention of endoscopic recurrence following surgery for Crohn's disease [abstract]. Gastroenterology 2008; 134 (Suppl 1):A-361.
32. D'Haens GR, Vermeire S, Van Assche G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology 2008; 135:1123-1129.
33. Domenech E, Mañosa M, Bernal I, et al. Impact of azathioprine therapy on the prevention of postoperative Crohn's disease recurrence: results of a prospective, observational, long-term follow-up study. Inflamm Bowel Dis 2008; 14:508-513.
34. Peyrin-Biroulet L, Deltenre P, Ardizzone S, et al. Azathioprine and 6-mercap-topurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis. Am J Gastroenterol 2009; 104:2089-2096.
35. Sorrentino D, Terrosu G, Avellini C, et al. Infliximab with low-dose methotrexate for prevention of postoperative Crohn's disease recurrence of ileo-colonic Crohn's disease. Arch intern Med 2007; 167:1804-1807.
36. Yoshimura N, Kawaguchi T, Sako M, Takazoe M. Clinical efficacy of infliximab in the management of postsurgical recurring Crohn's disease [abstract]. Gastroenterology 2008; 134 (suppl 1):A-472.
37. Yamamoto T, Umegae S, Matsumoto K. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study. Inflamm Bowel Dis 2009; 15:1460-1466.
38. Regueiro M, Schraut W, Baidoo L, et al. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology 2009; 136:441-450.
39. Regueiro M, Schraut WH, Baidoo L, et al. Infliximab initiated shortly after Crohn's disease (CD) resection is not associated with increased postoperative adverse events [abstract]. Gastroenterology 2009; 136 (Suppl 1):A-202.
40. Regueiro M, Schraut WH, Baidoo L, et al. Two year follow-up of patients enrolled in the randomized controlled trial (RCT) of infliximab (IFX) for prevention of recurrent Crohn's disease (CD) [abstract]. Gastroenterology 2009; 136 (Suppl 1):A-522.